How Long Can You Microdose Semaglutide — and Should You?

What microdosing actually means in this context

The term "microdosing" is borrowed from pharmacology and gets used loosely by online communities to describe staying at the 0.25 mg or 0.5 mg starting doses of semaglutide rather than titrating toward the 2.4 mg maintenance dose. It is not a term used in the licensed prescribing information. The Wegovy dosing schedule begins at 0.25 mg as a tolerability measure, your body adjusting to a new mechanism, not a therapeutic plateau. From there, titration typically moves in roughly four-week steps through 0.5 mg, 1.0 mg, 1.7 mg, and then 2.4 mg, with a prescriber guiding each step.

Staying below the maintenance dose is not inherently wrong. Some people find that nausea or other gastrointestinal effects are significant enough at higher doses that their prescriber holds them at a lower level while symptoms settle. Others simply feel they are progressing well and want to avoid pushing further. The clinical question is whether the current dose is doing enough useful work to justify continuing, and that is something the clinical team assesses at each review, not a call the patient makes alone.

How long staying at a lower dose is reasonable

There is no published ceiling, no guidance from NICE or the MHRA that says "you must titrate within X weeks or stop". What the NICE appraisal of semaglutide for weight management (TA875) does say is that clinicians should consider stopping treatment if less than 5% weight loss has been achieved after six months on the maintenance dose. That is a rule about the maintenance dose, not lower ones. It implies that staying at a sub-maintenance level indefinitely, without progressing, would need good clinical justification, particularly if weight loss has stalled.

In practice, a prescriber might hold someone at 0.5 mg or 1.0 mg for several weeks if gastrointestinal side effects are significant, then attempt titration again once things settle. That is clinically reasonable and is part of how the schedule is designed to flex. Staying there for months because the internet suggested it is a different matter. If you are wondering how long you can take semaglutide more broadly, duration questions and dose questions are connected, both hinge on how your body is responding.

The side-effect angle: why some people stay low on purpose

The most common reason people resist titrating upward is gastrointestinal discomfort: nausea, loose stools, reflux, or a general unsettled feeling after dose changes. These effects are well-documented, typically peaking in the first few days after an increase and easing over one to two weeks for most people. The NHS patient information for semaglutide describes them as expected, and your prescriber or patient information leaflet will cover what to watch for.

Staying at a lower dose to manage these effects is a legitimate strategy, for a period. The practical question is whether you are genuinely managing a temporary reaction or whether you are effectively opting out of the treatment. Nausea that arrived with a Tuesday morning injection and fades by Thursday is different from symptoms that last all week. Keep notes. Tell your prescriber what is actually happening, not what you think they want to hear. One question our prescribers hear regularly is whether side effects will ease with time, and for most people, with a bit of patience after each step, they do.

Making the decision with your prescriber, not instead of one

If you are weighing up whether to stay at your current dose, push forward, or consider how long your semaglutide course might run in total, that conversation belongs in a clinical review. At nume (sorry, at our pharmacy) every repeat order goes through a clinical re-review before it is approved. There are no auto-renewals. That structure exists precisely so these decisions get made properly, not by default.

Cost is sometimes the thing that nudges people toward lower doses: less medicine used, perhaps a different cadence of orders. If that is part of your thinking, the Wegovy price comparison page sets out what private treatment typically costs in the UK and what legitimate pricing looks like, which is worth reading before making any dose decisions on financial grounds. Price is genuinely the wrong test for a prescription medicine; safety and clinical progress are the right ones.

Reach out via our support team if you have questions between reviews, and if you are new to all of this, speak to our prescribers through a free consultation to find out whether Wegovy is appropriate for you in the first place.